Multiple Myeloma

Multiple myeloma—a cancer that forms in a type of blood cell called a plasma cell—is a chronic disease that requires ongoing care and monitoring. Our team of specialists partners with you throughout diagnosis and treatment. We use sophisticated diagnostic and genetic tests, some of which were developed at NYU Langone, to guide treatment planning. We also draw upon recent medical advances to provide you with customized therapy. Our doctors have conducted clinical trials to help establish a number of the medications in use today, including immune therapies and targeted medications.

Clinical Trials and Research Studies

Phase 2

A Phase 2b Open-Label Single-Arm Study of Selinexor (KPT-330) plus Low-Dose Dexamethasone in Patients with Multiple Myeloma Quad-refractory to Previous Therapies

Learn More